AK106-001616 Uses, Dosage, Side Effects and more
AK106-001616 is under investigation in clinical trial NCT01285752 (A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)).
Trade Name | AK106-001616 |
Generic | AK106-001616 |
Type | |
Formula | C26H25N3O3 |
Weight | Average: 427.504 Monoisotopic: 427.189591677 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |